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ABSTRACT 
N-3 fatty acids, such as fish oil, have been reported to 
have some beneficial effects in patients with bronchial 
asthma. The effects of dietary supplementation
with perilla seed oil rich in α-linolenic acid (α-LNA),
parent n-3 tatty acid, were studied in five patients with 
asthma. The symptoms of asthma and mean peak 
flow rates (PFR) both early in the morning and in 
the evening were improved 2 weeks after dietary 
supplementation and the increases in PFR were 
significant (P<0.05). The generation of leukotriene 
B4 (LTB4) by peripheral leukocytes stimulated with 
the Ca2+ ionophore A23187 was significantly
suppressed from 77.6 to 41.6ng/5×106 cells by
dietary supplementation (P<0.05). The generation 
of leukotriene C4 (LTC4) by leukocytes was also
significantly suppressed from 64.0 to 38.8ng/5×106
cells after supplementation with perilla seed oil 
(P<0.05). These results suggest that dietary 
supplementation with perilla seed oil is beneficial for 
the treatment of asthma. 
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leukotriene C4, peak flow, perilla seed oil.
INTRODUCTION 
Many kinds of chemical mediators from inflammatory 
cells are involved in the pathogenesis of bronchial 
sthma. Among these, leukotrienes (LT) are one of the 
most important chemical mediators in asthma. Peptide 
leukotrienes (LTC4, D4 and E4) have a bronchoconstrictor 
action and participate in the onset of asthma attacks.1,2 
Leukotriene B4, known as a strong chemotactic factor, 
also plays an important role in the process of asthmatic 
response by recruiting leukocytes to allergic reaction sites 
in th airway. These LT are generated from arachidonic 
acid (AA), which is released from membrane phospho-
lipids during cell activation, through the 5-lipoxygenase 
pathway.3 
 It has been suggested that dietary supplementation 
with polyunsaturated fatty acids (PUFA) is beneficial 
for the treatment of various chronic diseases. Of the
PUFA, omega (ω)-3 or n-3 fatty acids, such as
eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), are known to protect against the progress of 
cardiovascular disease by competitively inhibiting the 
conversion of AA to LT and prostanoids, forming fewer 
active metabolites, such as LTB5 and thromboxane A3.
α-Linolenic acid (αLNA), the n-3 parent fatty acid,
has been reported to suppress the synthesis of LT; 
however, its effects in humans are not as well known 
as those of EPA and DHA. In bronchial asthma, the 
effects of supplementation with n-3 fatty acids are 
controversial.6 Several reports that have focused chiefly 
on the effects offish oil or EPA have suggested beneficial 
effects of n-3 fatty acids on asthma and allergic 
rhinitis.7-10
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In the present study the effects of αLNA-enriched perilla
seed oil on bronchial asthma were examined with regard 
to symptoms, ventilatory function, generation of LTB4 and 
LTC4 by leukocytes and changes in the composition of 
plasma phospholipid fatty acids.
METHODS 
Patients 
The subjects included four patients (four females) with 
bronchial asthma and one patient (female) with cough-
variant asthma (CVA). All patients were admitted to 
Misasu Branch Hospital for treatment of asthma. The 
clinical backgrounds of these patients are given in Table 
1. The mean age of the patients was 60.2 years (range 
51-72 years) and the mean level of serum IgE was 70.4 
IU/mL. All bronchial asthma patients had been taking
long-acting oral theophylline, inhaled β2 adrenergic
agonists and inhaled glucocorticoid (beclomethasone) 
regularly. Two of five subjects with asthma had been 
taking systemic corticosteroids. The doses of inhaled and 
oral corticosteroids and of oral theophylline did not 
change during the study period. Clinical symptoms, such 
as cough, wheeze, daytime activity, volume of sputum 
and dyspnea were observed daily and were assessed by 
being scored according to the evaluation system 
developed by the Committee of the Japanese Society of 
Allergology. Peak flow rates (PFR) before and after
inhalation of β2 agonists in the early morning and in the
evening were recorded using a peak flow meter (Assess: 
Health Scan Products Inc., Cedar Grove, NJ, USA).
Bronchial reactivity to β2 agonists was estimated in all
patients by observing the improvement of morning PFR 
after inhalation of salbutamol. The improvement in the
morning PFR by the inha-ation of a β2 agonist was 40%
before dietary supplementation.
 Subjects consumed 15g/day perilla seed oil as a salad 
dressing and/or mayonnaise instead of other oils for 2 
weeks. Other dietary components were not changed and 
the amount of oil used in the diet and supplemented diet 
was recorded throughout the study period.
Measurement of LT 
The generation of LTB4 and LTC4 by peripheral leukocytes 
was assessed as previously described1,11,12 Cells were 
separated by counterflow centrifugation elutriation with a 
JE 6B rotor (Beckman Co., Palo Alto, CA, USA),13 as 
described previously.14 After the number of cells was
adjusted to 5×106/mL in Tris ACM (composition: 1LmL
of 0.1mol/L CA2+, 0.5mL of 0.1mol/L Mg2+ and 98.5 
mL Tris A buffer; Trizma preset crystal, pH 7.7; Sigma 
Chemical Co., St Louis, Mo, USA) the Ca2+ ionophore
A23187 (1μg) was added to the cell suspension. The
mixed solution was incubated for 15min at 37℃ and
was centrifuged at 300g for 10min at 4℃. High
pressure liquid chromatography (HPLC) analysis of the 
extraction and quantification of LTB4 and LTC4 was 
performed as described by Lam et al.15 The extraction of 
LT was performed using a C18 Sep-Pak (Waters 
Associates, Milford, MA, USA). The concentrations of 
LTB4 and LTC4 were analyzed by a HPLC system (model 
510; Waters Associates) equipped with an ultraviolet (UV)
detector. The column used was a 5mm×10cm Radial-
Pak cartridge (Shimadzu Co., Kyoto, Japan). Results are
expressed as ng/5×106 cells.
Statistics 
Statistically significant differences between means were 
estimated using the paired Student's t-test. A P value of 
<0.05 was regarded as significant.
Table 1. Clinical background and medication of patients with asthma
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RESULTS 
Improvement of symptoms and ventilatory 
function 
Symptoms of asthma tended to improve in all subjects 1 
week after dietary supplementation with perilla seed oil. 
In evaluations of improvements by scoring the symptoms, 
therapy and symptom + therapy, the mean of all scores 
tended to decrease after dietary supplementation. The 
asthma score (symptom score + therapeutic score) 
decreased from 186.1 to 162.9 after 2 weeks dietary 
supplementation with perilla seed oil (Fig. 1). Mean PFR 
also improved after dietary supplementation and the 
percentage increase of PFR was 15 and 9% in the early 
morning and in the evening, respectively, after 2 weeks of 
dietary oil supplementation; these increases were 
significant (P<0.05; Fig. 2).
 In general, dietary supplementation with perilla seed 
oil was regarded by the patients' own doctors as effective 
in three of five patients (cases 1, 2 and 4) and relatively 
effective in one patient (case 3), while in one patient 
(case 5) it deemed to have had no effect. 
Reduction in generation of LTB4 and LTC4
The generation of LTB4 and LTC4 by leukocytes was 
suppressed by dietary supplementation with perilla seed
oil (Fig. 3 The mean (±SD) level of LTB4 generation
before supplementation was 77.6±24.4ng/5×106
cells; this value was significantly decreased to
Fig. 1 Changes of symptom (■), therapeutic (●) and asthma
(▼) scores before and after perilla seed oil supplementation.
The scores tended to decrease after perilla seed oil 
supplementation. Vertical bars represent standard errors.
Fig. 2 Changes of peak flow rates before and after perilla seed
oil supplementation. Peak flow rates both in the morning (-▲-)
and in the evening (-■-) were significantly increased after the
manipulation. Vertical bars represent standard errors.
Fig. 3 Leukotriene (LT) synthesis by peripheral leukocytes 
stimulated by CA2+ i ophore A23187 before and after perilla
seed oil supplementation. Synthesis of LTB4 (●) and LTC4 (■) was
ignificantly suppressed after perilla seed oil supplementation.
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41.6±24.9ng/5×106 cells after dietary supplementa-
tion with perilla seed oil (P<0.05; Fig. 3).The generation 
of LTC4 by leukocytes was also significantly decreased by 
dietary supplementation with perilla seed oil from
64.0±33.5 to 38.8±23.2ng/5×106 cells (P<0.05;
Fig. 3).
DISCUSSION 
Bronchial allergen challenge induces an immediate 
asthmatic reaction (IAR) within 30min and a late 
asthmatic reaction (LAR), which occurs 6-8h after the 
challenge. The LAR, in which inflammatory cells such 
as lymphocytes, neutrophils, eosinophils and basophils 
migrate into allergic reaction sites in the airway,2,16is 
closely associated with bronchial hyperresponsive-
ness.20,21 Leukotrienes, one of the major chemical 
mediators in asthma, play important roles in the LAR. In 
the treatment of asthma it is important to suppress the 
[AR, which is closely related to the severity of the asthma. 
It has been reported that a reduction in the LAR of asthma 
patients was produced by dietary supplementation 
with fish oil; however, no beneficial effects of n-3 fatty 
acids were observed in many patients with asthma with 
regard to PFR, symptom score and the need for 
bronchodilators.7 Another report has shown that subjects 
taking EPA capsules containing 3.2g EPA and 
2.2g DHA, had a blunted LAR to allergen challenge.8 
Dry et al. have also reported that asthma patients taking 
fish oil chronically appeared to have a statistically 
significant improvement in pulmonary function.9 In 
patients with hayfever accompanied by asthma, a 
significant reduction in nasal symptoms during the pollen 
season, but not in the asthma symptoms, was observed 
following dietary supplementation with fish oil.10
 Leukotrienes are synthesized by inflammatory cells in 
large amounts during allergic reactions. Sulfidopeptide 
LT of the 'five series' (LTC5,5 and E5) from EPA have 
relatively similar properties to those of the 'four series' 
(LTC4i D4 and E4) from arachidonate.22 In contrast, the 
generation of LTB4, which is chemotactic and recruits 
many inflammatory cells to the focus of inflammation, is 
reduced by n-3 fatty acids23,24 and both LTB4 from AA and 
LTB5 from EPA have similar biological activities. The 
action of LTB4 is, however, very weak compared with that 
of LTB4. In contrast, cyclooxygenase products from EPA 
have different biological activities to those from AA. 
Thromboxane A3 does not stimulate platelets in the way 
that thromboxane A2 does. Leukotriene B5 and
thromboxane A3 made from n-3 fatty acids are different in 
the degree and character of their biological activities to 
LTB4 and thromboxane A2, derived from arachidonate.
In the present study the effects of αLNA on asthma
symptoms and the generation of LTB4 and LTC4 were 
examined in patients with asthma. The results showed 
that asthma symptoms and morning PFR were improved
after α-LNA-enriched p rilla seed oil supplementation of
the diet. These results suggest that perilla seed oil 
supplementation is beneficial for the treatment of 
asthma.
 In bronchial asthma, studies of n-3 fatty acids are 
focused chiefly on the supplementation with EPA 
capsules.6-10 However, few studies have been performed 
regarding the benefits of dietary supplementation with 
aLNA. The present study using perilla seed oil as a salad 
dressing or mayonnaise is an initial step to develop a diet 
therapy for asthma patients. Further studies are needed to 
d velop a nutritionally balanced diet therapy for 
bronchial asthma.
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